Human Chorionic Gonadotropin (hCG) market, valued at a substantial USD 380 million in 2024, is a critical component of this healthcare landscape. This robust foundation is set for impressive growth, with projections indicating the market will expand from USD 410 million in 2025 to USD 620 million by 2032.
